Midodrine prescribed to improve recurrent post-spaceflight orthostatic hypotension

Aviation Space and Environmental Medicine

Volumn 75, Issue 6, 2004, Pages 554-556

  Platts, Steven H ^a   Ziegler, Michael G ^b   Waters, Wendy W ^c   Mitchell, Brett M ^a   Meck, Janice V ^d  

^a UNIVERSITIES SPACE RESEARCH ASSOCIATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WYLE LABORATORIES   (United States)

^d NASA JOHNSON SPACE CENTER   (United States)

Author keywords

1 adrenergic agonist; Microgravity; ST 1059; Venous return

Indexed keywords

2 AMINO 1 (2,5 DIMETHOXYPHENYL)ETHANOL; DRUG METABOLITE; MIDODRINE;

ADULT; ARTICLE; CASE REPORT; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; FLIGHT; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; HUMAN; HYPOTENSION; MICROGRAVITY; ORTHOSTATIC HYPOTENSION; PRESCRIPTION; RECURRENT DISEASE; SPACE FLIGHT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VASCULAR RESISTANCE;

NASA CENTER JSC; NASA DISCIPLINE CARDIOPULMONARY;

FLIGHT EXPERIMENT; MANNED; SHORT DURATION; STS SHUTTLE PROJECT;

ADRENERGIC ALPHA-AGONISTS; CARDIAC OUTPUT; FEMALE; HEART RATE; HUMANS; HYPOTENSION, ORTHOSTATIC; MIDODRINE; RECURRENCE; SPACE FLIGHT; STROKE VOLUME;

EID: 2442710343     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Al Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. J Am Med Assoc 2003; 289:2120-7.
2. Fritsch-Yelle JM, Whitson PA, Bondar RL, Brown TE. Subnormal norepinephrine release relates to presyncope in astronauts after spaceflight. J Appl Physiol 1996; 81:2134-41.
3. Grobecker HF, Kees F. Pharmacokinetic parameters and haemodynamic actions of midodrine in young volunteers. Int Angiol 1993; 12:119-24.
4. Kaufmann H, Brannan T, Krakoff L, et al. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 1988; 38:951-5.
5. Low PA, Gilden JL, Freeman R, et al. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. JAMA 1997; 277:1046-51.
6. 1-adrenergic receptor responses before flight and central autonomic dysregulation post-flight. Am J Physiol Heart Circ Physiol 2004; 286: H1486-95.
7. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: A review. Am J Cardiol 1993; 72:23B-5B.
8. Ramsdell CD, Mullen TJ, Sundby GH, et al. Midodrine prevents orthostatic intolerance associated with simulated spaceflight. J Appl Physiol 2003; 90:2245-8.
9. Waters WW, Ziegler MG, Meck JV. Postspaceflight orthostatic hypotension occurs mostly in women and is predicted by low vascular resistance. J Appl Physiol 2002; 92:586-94.
10. Zachariah PK, Bloedow DC, Moyer TP, et al. Pharmacodynamics of midodrine, an antihypotensive agent. Clin Pharmacol Ther 1986; 39:586-91.